Alexandra Grassian

3.4k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Alexandra Grassian is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Alexandra Grassian has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Alexandra Grassian's work include Cancer, Hypoxia, and Metabolism (6 papers), Mitochondrial Function and Pathology (3 papers) and Chromatin Remodeling and Cancer (3 papers). Alexandra Grassian is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Mitochondrial Function and Pathology (3 papers) and Chromatin Remodeling and Cancer (3 papers). Alexandra Grassian collaborates with scholars based in United States, Switzerland and Israel. Alexandra Grassian's co-authors include Joan S. Brugge, Zachary T. Schafer, Hanna Y. Irie, Zhenyang Jiang, Sizhen Gao, Loling Song, Pere Puigserver, Zachary Gerhart‐Hines, Christian M. Metallo and Raymond Pagliarini and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Alexandra Grassian

17 papers receiving 1.7k citations

Hit Papers

Antioxidant and oncogene rescue of metabolic defects caus... 2009 2026 2014 2020 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Grassian United States 12 1.2k 797 367 166 125 17 1.7k
Ciro Zanca United States 18 1.3k 1.0× 793 1.0× 296 0.8× 158 1.0× 107 0.9× 25 1.8k
Lynn Kirkpatrick United States 15 991 0.8× 679 0.9× 295 0.8× 111 0.7× 179 1.4× 23 1.6k
Anna L. Stratford Canada 24 1.2k 1.0× 445 0.6× 567 1.5× 96 0.6× 130 1.0× 27 1.9k
Esther Bridges United Kingdom 21 1.1k 0.9× 744 0.9× 430 1.2× 72 0.4× 130 1.0× 38 1.7k
Oona Delpuech United Kingdom 20 1.1k 0.8× 460 0.6× 433 1.2× 92 0.6× 243 1.9× 33 1.7k
Anica Dricu Romania 26 811 0.7× 423 0.5× 374 1.0× 317 1.9× 158 1.3× 78 1.6k
Chang Hun Rhee South Korea 22 968 0.8× 405 0.5× 287 0.8× 268 1.6× 196 1.6× 34 1.8k
Georgios Kallifatidis United States 18 940 0.8× 364 0.5× 646 1.8× 213 1.3× 124 1.0× 26 1.7k
Estefanía Carrasco‐García Spain 25 817 0.7× 412 0.5× 387 1.1× 223 1.3× 116 0.9× 37 1.4k
Michael Milyavsky Israel 23 1.5k 1.2× 456 0.6× 725 2.0× 126 0.8× 148 1.2× 47 2.1k

Countries citing papers authored by Alexandra Grassian

Since Specialization
Citations

This map shows the geographic impact of Alexandra Grassian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Grassian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Grassian more than expected).

Fields of papers citing papers by Alexandra Grassian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Grassian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Grassian. The network helps show where Alexandra Grassian may publish in the future.

Co-authorship network of co-authors of Alexandra Grassian

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Grassian. A scholar is included among the top collaborators of Alexandra Grassian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Grassian. Alexandra Grassian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Grassian, Alexandra, Andrew M. Haidle, James Α. Baker, et al.. (2024). BLU-808, a Potent and Selective Small Molecule Inhibitor of Wild-type c-KIT for Mast Cell Disorders. Journal of Allergy and Clinical Immunology. 153(2). AB62–AB62. 4 indexed citations
2.
House, Nealia C., et al.. (2023). CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. NAR Cancer. 5(3). zcad039–zcad039. 15 indexed citations
3.
Serrano, César, Sebastian Bauer, Yoon‐Koo Kang, et al.. (2022). Circulating tumor DNA (ctDNA) analyses of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor (GIST).. Journal of Clinical Oncology. 40(16_suppl). 101–101. 4 indexed citations
4.
Chan-Penebre, Elayne, Kelli Armstrong, Allison E. Drew, et al.. (2017). Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models. Molecular Cancer Therapeutics. 16(5). 850–860. 127 indexed citations
5.
Kawano, Satoshi, Alexandra Grassian, Masumi Tsuda, et al.. (2016). Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma. PLoS ONE. 11(7). e0158888–e0158888. 58 indexed citations
6.
Grassian, Alexandra, Sarah K. Knutson, Kevin W. Kuntz, et al.. (2015). A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene Essentiality. Biological Procedures Online. 17(1). 15–15. 5 indexed citations
7.
Grassian, Alexandra, Seth J. Parker, Shawn M. Davidson, et al.. (2014). IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism. Cancer Research. 74(12). 3317–3331. 211 indexed citations
8.
Grassian, Alexandra, Seth J. Parker, Ajit S. Divakaruni, et al.. (2014). IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism. DSpace@MIT (Massachusetts Institute of Technology). 83 indexed citations
9.
Grassian, Alexandra, Raymond Pagliarini, & Derek Y. Chiang. (2014). Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology. 30(3). 295–302. 42 indexed citations
10.
Grassian, Alexandra, Seth J. Parker, Shawn M. Davidson, et al.. (2014). Abstract LB-139: IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Research. 74(19_Supplement). LB–139. 2 indexed citations
11.
Grassian, Alexandra, Fallon Lin, Rosemary Barrett, et al.. (2012). Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT). Journal of Biological Chemistry. 287(50). 42180–42194. 83 indexed citations
12.
Locasale, Jason W., Alexandra Grassian, Rameen Beroukhim, et al.. (2012). Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. BMC Proceedings. 6(S3). 2 indexed citations
13.
Grassian, Alexandra, Christian M. Metallo, Jonathan L. Coloff, Gregory Stephanopoulos, & Joan S. Brugge. (2011). Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes & Development. 25(16). 1716–1733. 146 indexed citations
14.
Grassian, Alexandra, Zachary T. Schafer, & Joan S. Brugge. (2010). ErbB2 Stabilizes Epidermal Growth Factor Receptor (EGFR) Expression via Erk and Sprouty2 in Extracellular Matrix-detached Cells. Journal of Biological Chemistry. 286(1). 79–90. 38 indexed citations
15.
Jagani, Zainab, Keli Song, Jeffery L. Kutok, et al.. (2009). Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors. Cancer Research. 69(16). 6546–6555. 40 indexed citations
16.
Schafer, Zachary T., Alexandra Grassian, Loling Song, et al.. (2009). Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 461(7260). 109–113. 808 indexed citations breakdown →
17.
Song, Keli, et al.. (2007). Apoptotic Pathways in Tumor Progression and Therapy. Advances in experimental medicine and biology. 615. 47–79. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026